A Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find optimistic dose and to evaluate the efficacy and safety
of SK-PC-B70M in patients with mild to moderate Alzheimer's disease.